Immatics N.V.

The momentum for this stock is not very good. Immatics N.V. is a mediocre stock to choose.

News

Immatics (NASDAQ:IMTX) Holdings Raised by TD Asset Management Inc

Ticker Report TD Asset Management Inc grew its holdings in shares of Immatics (NASDAQ:IMTX - Free Report) by 11.8% during the second quarter, according to its most recent filing with the Securities and Exchange...\n more…

Immatics (NASDAQ:IMTX) Rating Reiterated by Cantor Fitzgerald

Zolmax Immatics (NASDAQ:IMTX - Get Free Report)s stock had its "overweight" rating reissued by Cantor Fitzgerald in a research report issued on Thursday, Benzinga reports.\nSeparately, Mizuho upped...\n more…

Immatics Announces Upcoming Oral Presentation at the Society for Melanoma Research Congress 2024

Globe Newswire Houston, Texas and Tuebingen, Germany, September 06, 2024 Immatics N.V. (NASDAQ: IMTX, Immatics or the Company ), a clinical-stage biopharmaceutical company active in the discovery and...\n more…

IMTX Makes Notable Cross Below Critical Moving Average

Market News Video In trading on Thursday, shares of Immatics NV (IMTX) crossed below their 200 day moving average of 11.14, changing hands as low as 11.09 per share. Immatics NV shares are currently trading...\n more…

FY2024 Earnings Estimate for Immatics (NASDAQ:IMTX) Issued By Cantor Fitzgerald

Ticker Report Immatics (NASDAQ:IMTX - Free Report) - Cantor Fitzgerald increased their FY2024 earnings per share estimates for Immatics in a research note issued on Wednesday, August 14th. Cantor Fitzgerald...\n more…

Q3 2024 Earnings Estimate for Immatics Issued By Leerink Partnrs (NASDAQ:IMTX)

Zolmax Immatics (NASDAQ:IMTX - Free Report) - Research analysts at Leerink Partnrs cut their Q3 2024 EPS estimates for Immatics in a note issued to investors on Tuesday, August 13th. Leerink Partnrs...\n more…